Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects.
Complement C1q-C3 associated synaptic changes in multiple sclerosis hippocampus.
P wave duration and dispersion and QT interval in multiple sclerosis.
CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic elimination.
Identifying the biomarkers of multiple sclerosis based on non-coding RNA signature.
Nutraceuticals against Neurodegeneration: A Mechanistic Insight.
Antigen-Specific Binding of Multivalent Soluble Antigen Arrays Induces Receptor Clustering and Impedes B Cell Receptor Mediated Signaling.
Heterogeneity of acute multiple sclerosis lesions on sodium (23Na) MRI.
Prediction of disease severity in neuromyelitis optica by the levels of IL-6 produced during remission phase.
Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers.
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency in people with multiple sclerosis: a summary of a Cochrane systematic review.
Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis.
Multiple Sclerosis in the Levant: A Regional Consensus Statement.
Proteinticle Engineering for Accurate 3D Diagnosis.
Depression and sleep disturbances in patients with multiple sclerosis and correlation with associated fatigue.
The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells.
Revised diagnostic criteria of multiple sclerosis.
Inflammatory bowel disease: An increased risk factor for neurologic complications.
MS nurses join project to prove the value of specialist role.
[Anaesthetic management of patient with neurological disease: Focus on regional anaesthesia.]
Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model.
Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?
Charcot-Marie-Tooth disease: Frequency of genetic subtypes in a German neuromuscular center population.
Ligands for Ser/Thr phosphoprotein phosphatases: a patent review (2005-2015).

Pages